[Silicon, bone tissue and immunity].
The authors study the activity of a soluble salt of silicium on the evolution of the trabecular bone volume (TBV). They note a significant increase in the TBV, both in drinkable and in injectable form, in relation to a control population not receiving osteotrope medication. They moreover note, in a series of patients treated with silicium compared to a control group, a net increase in circulating lymphocytes and immunoglobulins (especially IgG).
D000328:Adult; D000368:Aged; D001842:Bone and Bones / Q000033:anatomy & histology / Q000187:drug effects*; D005260:Female; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D007136:Immunoglobulins / Q000378:metabolism; D007958:Leukocyte Count; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy / Q000276:immunology; D012825:Silicon / Q000494:pharmacology* / Q000627:therapeutic use
D007136:Immunoglobulins; D012825:Silicon
Silicium, tissu osseux et immunité.